Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study

This publication has 41 references indexed in Scilit:

• Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2011
• C-reactive protein in the Heart Protection Study – Authors' reply
  The Lancet, 2011
• C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
  The Lancet, 2011
• Progression of Coronary Artery Calcium Predicts All-Cause Mortality
  JACC: Cardiovascular Imaging, 2010
• Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction
  JAMA, 2010
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
  The Lancet, 2010
• C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
  The Lancet, 2010
• Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population
  JACC, 2009
• Inflammation in Atherosclerosis
  JACC, 2009
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  New England Journal of Medicine, 2008